Please use this identifier to cite or link to this item:
Title: Cyclosporine A enhances gluconeogenesis while sirolimus impairs insulin signaling in peripheral tissues after 3 weeks of treatment
Authors: Lopes, P. C. 
Fuhrmann, A. 
Carvalho, F. 
Sereno, J. 
Santos, M. R. 
Pereira, M. J. 
Eriksson, J. W. 
Reis, F. 
Carvalho, E. 
Keywords: Immunosuppressive agents; Insulin signaling; Gluconeogenesis; Adipocyte; Muscle; Liver
Issue Date: 1-Sep-2014
Publisher: Elsevier
Citation: LOPES, P. C. [et. al] - Cyclosporine A enhances gluconeogenesis while sirolimus impairs insulin signaling in peripheral tissues after 3 weeks of treatment. "Biochemical Pharmacology". ISSN 0006-2952. Vol. 91 Nº. 1 (2014) p. 61-73
Serial title, monograph or event: Biochemical Pharmacology
Volume: 91
Issue: 1
Abstract: Cyclosporine A (CsA) and sirolimus (SRL) are immunosuppressive agents (IA) associated with new-onset diabetes after transplantation (NODAT). This study aims to evaluate the effects of 3-weeks of treatment with either CsA (5 mg/kg BW/day) or SRL (1 mg/kg BW/day) on insulin signaling and expression of markers involved in glucose metabolism in insulin-sensitive tissues, in Wistar rats. Although no differences were observed in fasting glucose, insulin or C-peptide levels, both treated groups displayed an impaired glucose excursion during both glucose and insulin tolerance tests. These results suggest glucose intolerance and insulin resistance. An increase in glucose-6-phosphatase protein levels (68%, p < 0.05) and in protein-tyrosine phosphatase 1B (163%, p < 0.05), a negative regulator of insulin was observed in the CsA-treated group in the liver, indicating enhanced gluconeogenesis and increased insulin resistance. On the other hand, glucokinase protein levels were decreased in the SRL group (35%, p < 0.05) compared to vehicle, suggesting a decrease in glucose disposal. SRL treatment also reduced peroxisome proliferator-activated receptor γ coactivator 1 alpha protein expression in muscle (∼50%, p < 0.05), while no further protein alterations were observed in muscle and perirenal adipose tissue nor with the CsA treatment. Moreover, the phosphorylation of key proteins of the insulin signaling cascade was suppressed in the SRL group, but was unchanged by the CsA treatment. Taken together, these data suggest that CsA treatment enhances gluconeogenic factors in liver, while SRL treatment impairs insulin signaling in peripheral tissues, which can contribute to the development of insulin resistance and NODAT associated with immunosuppressive therapy.
ISSN: 0006-2952
DOI: 10.1016/j.bcp.2014.06.014
Rights: openAccess
Appears in Collections:I&D IBILI - Artigos em Revistas Internacionais
I&D CNC - Artigos em Revistas Internacionais
FMUC Medicina - Artigos em Revistas Internacionais
I&D CIBIT - Artigos em Revistas Internacionais

Files in This Item:
Show full item record


checked on Nov 9, 2022

Citations 10

checked on Aug 2, 2022

Page view(s) 50

checked on Nov 28, 2022

Download(s) 50

checked on Nov 28, 2022

Google ScholarTM




Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.